SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-026095
Filing Date
2023-07-28
Accepted
2023-07-28 16:08:43
Documents
14
Period of Report
2023-07-28
Items
Item 5.04: Temporary Suspension of Trading Under Registrant's Employee Benefit Plans
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20230728.htm   iXBRL 8-K 33821
2 EX-99.1 exhibit991-8xk072823.htm EX-99.1 15008
  Complete submission text file 0001628280-23-026095.txt   245794

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20230728.xsd EX-101.SCH 3364
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20230728_def.xml EX-101.DEF 18365
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20230728_lab.xml EX-101.LAB 36196
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20230728_pre.xml EX-101.PRE 18807
8 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20230728_htm.xml XML 6235
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 231123095
SIC: 2834 Pharmaceutical Preparations